Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Epsilon Healthcare Limited ( (AU:EPN) ).
Epsilon Healthcare Limited has released its 2025 Annual Report, which includes the chairman’s note, CEO report, directors’ report, remuneration details, and full audited financial statements. The document also covers shareholder information and standard governance declarations, underscoring the company’s commitment to transparent reporting and regulatory compliance for investors and regulators.
The report’s structure signals a focus on corporate oversight, executive remuneration, and detailed financial performance, though no specific figures or strategic initiatives are disclosed in the available excerpt. For stakeholders, the publication primarily confirms that Epsilon Healthcare has completed its annual reporting cycle with the usual breadth of information expected from a listed healthcare company.
The most recent analyst rating on (AU:EPN) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on Epsilon Healthcare Limited stock, see the AU:EPN Stock Forecast page.
More about Epsilon Healthcare Limited
Epsilon Healthcare Limited operates in the healthcare sector. The limited information provided does not specify its exact products, services, or market focus, but the company prepares comprehensive annual reports containing standard corporate, financial, and governance disclosures for its stakeholders.
YTD Price Performance: -36.36%
Average Trading Volume: 211,413
Technical Sentiment Signal: Sell
Current Market Cap: A$8.17M
For a thorough assessment of EPN stock, go to TipRanks’ Stock Analysis page.